{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:32:55Z","timestamp":1790652775906,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.mcna.2019.09.003","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T21:12:53Z","timestamp":1574197973000},"page":"109-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Drug Hypersensitivity Reactions"],"prefix":"10.1016","volume":"104","author":[{"given":"Mark S.","family":"Dykewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason K.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcna.2019.09.003_bib1","series-title":"Drug allergies","author":"Thong","year":"2014"},{"issue":"4","key":"10.1016\/j.mcna.2019.09.003_bib2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/all.12350","article-title":"International consensus on drug allergy","volume":"69","author":"Demoly","year":"2014","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.mcna.2019.09.003_bib3","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1365-2125.2010.03774.x","article-title":"Epidemiology and risk factors for drug allergy","volume":"71","author":"Thong","year":"2011","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.mcna.2019.09.003_bib4","first-page":"46","article-title":"Epidemiology of hypersensitivity drug reactions","volume":"42","author":"Gomes","year":"2010","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.mcna.2019.09.003_bib5","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0022-3476(84)81117-8","article-title":"Allergy to semisynthetic penicillins in cystic fibrosis","volume":"104","author":"Moss","year":"1984","journal-title":"J\u00a0Pediatr"},{"issue":"5","key":"10.1016\/j.mcna.2019.09.003_bib6","doi-asserted-by":"crossref","first-page":"e1424","DOI":"10.1542\/peds.2012-1575","article-title":"Incidence of rash after amoxicillin treatment in children with infectious mononucleosis","volume":"131","author":"Paret","year":"2013","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.mcna.2019.09.003_bib7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.anai.2010.08.002","article-title":"Drug allergy: an updated practice parameter","volume":"105","author":"Solensky","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.mcna.2019.09.003_bib8","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jaci.2010.08.025","article-title":"The role of penicillin in benign skin rashes in childhood: a prospective study based on drug rechallenge","volume":"127","author":"Caubet","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.mcna.2019.09.003_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2007.10.021","article-title":"Diagnosis and management of HIV drug hypersensitivity","volume":"121","author":"Davis","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.mcna.2019.09.003_bib10","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jaci.2016.08.002","article-title":"Pharmacogenomics and adverse drug reactions: Primetime and not ready for primetime tests","volume":"138","author":"Khan","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.mcna.2019.09.003_bib11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/clpt.1991.3","article-title":"Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions","volume":"49","author":"Rieder","year":"2010","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.mcna.2019.09.003_bib13","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/all.13132","article-title":"Precision medicine in allergic disease\u2014food allergy, drug allergy, and anaphylaxis\u2014PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology","volume":"72","author":"Muraro","year":"2017","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.mcna.2019.09.003_bib14","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jaci.2003.12.591","article-title":"Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003","volume":"113","author":"Motala","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.mcna.2019.09.003_bib16","first-page":"83","article-title":"Cutaneous drug reactions","volume":"6","author":"Khan","year":"1994","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.mcna.2019.09.003_bib17","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2125.2010.03703.x","article-title":"Skin manifestations of drug allergy","volume":"71","author":"Ardern-Jones","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.mcna.2019.09.003_bib18","series-title":"Fitzpatrick\u2019s dermatology in general medicine","article-title":"Chapter 91. Abnormal responses to ultraviolet radiation: idiopathic, probably immunologic, and photoexacerbated","author":"Vandergriff","year":"2012"},{"key":"10.1016\/j.mcna.2019.09.003_bib19","unstructured":"Pichler WJ. Drug allergy: classification and clinical features. In: Adkinson NF, editor. UpToDate. Waltham, MA: UpToDate Inc."},{"issue":"3","key":"10.1016\/j.mcna.2019.09.003_bib21","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1081-1206(10)63308-X","article-title":"Severe serum sickness-like reaction to oral penicillin drugs: Three case reports","volume":"86","author":"Tatum","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.mcna.2019.09.003_bib22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/BOR.0000000000000014","article-title":"Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis","volume":"26","author":"Pendergraft","year":"2014","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"10.1016\/j.mcna.2019.09.003_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archderm.139.1.45","article-title":"Drug-induced, Ro\/SSA-positive cutaneous lupus erythematosus","volume":"139","author":"Srivastava","year":"2003","journal-title":"Arch Dermatol"},{"issue":"7","key":"10.1016\/j.mcna.2019.09.003_bib24","first-page":"4431","article-title":"The vast majority of CLA+ T\u00a0cells are resident in normal skin","volume":"176","author":"Brinster","year":"2014","journal-title":"J\u00a0Immunol"},{"issue":"5","key":"10.1016\/j.mcna.2019.09.003_bib25","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nchembio.2334","article-title":"In silico design of novel probes for the atypical opioid receptor MRGPRX2","volume":"13","author":"Lansu","year":"2017","journal-title":"Nat Chem Biol"},{"issue":"1","key":"10.1016\/j.mcna.2019.09.003_bib26","first-page":"1","article-title":"MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia","volume":"8","author":"Serrano-Candelas","year":"2018","journal-title":"Sci Rep"},{"issue":"23","key":"10.1016\/j.mcna.2019.09.003_bib27","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa0803200","article-title":"Contaminated heparin associated with adverse clinical events and activation of the contact system","volume":"358","author":"Viswanathan","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2019.09.003_bib28","series-title":"An expert guide to allergy and immunology","first-page":"127","article-title":"Drug allergy","author":"Dykewicz","year":"1999"},{"issue":"2","key":"10.1016\/j.mcna.2019.09.003_bib29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jaci.2017.06.012","article-title":"Diagnosis and management of anaphylaxis in precision medicine","volume":"140","author":"Castells","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.mcna.2019.09.003_bib31","unstructured":"Castells MC, Solenksy R. Rapid drug desensitization for immediate hypersensitivity reactions. In: Adkinson NF, editor. UpToDate. Waltham (MA): UpToDate Inc. Accessed February 2, 2019."},{"issue":"1","key":"10.1016\/j.mcna.2019.09.003_bib32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jaip.2017.08.027","article-title":"Cross-reactivity in \u03b2-lactam Allergy","volume":"6","author":"Zagursky","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.mcna.2019.09.003_bib33","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jaip.2017.02.014","article-title":"Practical management of antibiotic hypersensitivity in 2017","volume":"5","author":"Macy","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.mcna.2019.09.003_bib34","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/jama.2018.19283","article-title":"Evaluation and management of penicillin allergy: a review","volume":"321","author":"Shenoy","year":"2019","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.mcna.2019.09.003_bib35","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.jaip.2018.01.020","article-title":"Cross-reactivity and tolerability of cephalosporins in patients with IgE-mediated hypersensitivity to penicillins","volume":"6","author":"Romano","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.mcna.2019.09.003_bib36","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jaci.2012.10.003","article-title":"Allergy to sulfonamides","volume":"131","author":"Schnyder","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2 SUPPL. 2","key":"10.1016\/j.mcna.2019.09.003_bib37","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1067\/mai.2003.93","article-title":"10. Drug allergy","volume":"111","author":"Gruchalla","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.mcna.2019.09.003_bib38","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.0105-1873.2004.00274.x","article-title":"Cross-reactivity among p-amino group compounds in sulfonamide fixed drug eruption: diagnostic value of patch testing","volume":"51","author":"Tornero","year":"2004","journal-title":"Contact Dermatitis"},{"issue":"17","key":"10.1016\/j.mcna.2019.09.003_bib39","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.2146\/ajhp120291","article-title":"Sulfonamide cross-reactivity: is there evidence to support broad cross-allergenicity?","volume":"70","author":"Wulf","year":"2013","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"10.1016\/j.mcna.2019.09.003_bib40","first-page":"16","article-title":"Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin ii receptor blockers for treating essential hypertension","volume":"148","author":"McCrory","year":"2013","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.mcna.2019.09.003_bib41","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jaip.2018.04.022","article-title":"Angioedema due to bradykinin dysregulation","volume":"6","author":"Cicardi","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"10","key":"10.1016\/j.mcna.2019.09.003_bib43","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jama.1990.03450100077030","article-title":"Severe angioedema related to ACE inhibitors in patients with a history of idiopathic angioedema","volume":"264","author":"Orfan","year":"1990","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.mcna.2019.09.003_bib44","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1097\/HJH.0b013e32834b4b9b","article-title":"Long-term follow-up of 111 patients with angiotensin-converting enzyme inhibitor-related angioedema","volume":"29","author":"Zanichelli","year":"2011","journal-title":"J\u00a0Hypertens"},{"issue":"5","key":"10.1016\/j.mcna.2019.09.003_bib45","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1081-1206(10)61766-8","article-title":"Fresh frozen plasma in the treatment of resistant angiotensin-converting enzyme inhibitor angioedema","volume":"92","author":"Warrier","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.mcna.2019.09.003_bib46","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jaci.2016.09.051","article-title":"Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema","volume":"140","author":"Straka","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.mcna.2019.09.003_bib47","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S1081-1206(10)60288-8","article-title":"Risk of angioedema with angiotensin receptor blockers in patients with prior angioedema associated with angiotensin-converting enzyme inhibitors: a meta-analysis","volume":"101","author":"Haymore","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.mcna.2019.09.003_bib48","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1345\/aph.1P630","article-title":"The role of angiotensin receptor blockers in patients with angiotensin-converting enzyme inhibitor-induced angioedema","volume":"45","author":"Beavers","year":"2011","journal-title":"Ann Pharmacother"},{"issue":"7","key":"10.1016\/j.mcna.2019.09.003_bib49","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1398-9995.2011.02557.x","article-title":"Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI\/ENDA and GA2LEN\/HANNA","volume":"66","author":"Kowalski","year":"2011","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.mcna.2019.09.003_bib50","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4168\/aair.2015.7.4.312","article-title":"Seven steps to the diagnosis of NSAIDs hypersensitivity: How to apply a new classification in real practice?","volume":"7","author":"Kowalski","year":"2015","journal-title":"Allergy Asthma Immunol Res"},{"issue":"3","key":"10.1016\/j.mcna.2019.09.003_bib51","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jaip.2016.10.021","article-title":"Current knowledge and management of hypersensitivity to aspirin and NSAIDs","volume":"5","author":"Laidlaw","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.mcna.2019.09.003_bib52","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2014.08.020","article-title":"Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature","volume":"135","author":"Rajan","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.mcna.2019.09.003_bib54","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.jaip.2018.04.005","article-title":"Twenty years\u2019 experience with anaphylaxis-like reactions to local anesthetics: genuine allergy is rare","volume":"6","author":"Trautmann","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.mcna.2019.09.003_bib55","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jaip.2018.01.004","article-title":"In\u00a0vitro diagnosis of immediate drug hypersensitivity during anesthesia: a review of the literature","volume":"6","author":"Ebo","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.mcna.2019.09.003_bib56","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jaip.2018.06.030","article-title":"Controversies in drug allergy: radiographic contrast media","volume":"7","author":"S\u00e1nchez-Borges","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.mcna.2019.09.003_bib57","unstructured":"Hong SJ, Cochran ST. Immediate hypersensitivity reactions to radiocontrast media: Prevention of recurrent reactions. In: Adkinson NF, editor. UpToDate. Waltham (MA): UpToDate Inc. Accessed February 2, 2019."},{"key":"10.1016\/j.mcna.2019.09.003_bib58","series-title":"ACR Committee on Drugs and Contrast Media. ACR Manual on Contrast Media. Version 10.3","first-page":"22","year":"2018"},{"issue":"11","key":"10.1016\/j.mcna.2019.09.003_bib60","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJMoa074943","article-title":"Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-\u03b1-1,3-Galactose","volume":"358","author":"Gold","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.mcna.2019.09.003_bib61","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jaci.2008.02.044","article-title":"Hypersensitivity reactions to chemotherapy: Outcomes and safety of rapid desensitization in 413 cases","volume":"122","author":"Castells","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002571251930104X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002571251930104X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T17:49:49Z","timestamp":1574444989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002571251930104X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S002571251930104X"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2019.09.003","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug Hypersensitivity Reactions","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2019.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}